Heart Failure Long-Term Registry
description
Transcript of Heart Failure Long-Term Registry
![Page 1: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/1.jpg)
Heart Failure Long-Term Registry
KORONARNA BOLEST I SRČANA SLABOST U SKB MOSTAR
Prim.Doc.Dr Emir Fazlibegović, ESC, FESCProf.Dr Mustafa Hadžiomerović, ESC, FESC
Doc.Dr Danijel PravdićDr Benjamin Palić
27.9.2012., Hotel Bristol
Internacionalni naučni simpozijum Svjetski dan srca 2012 u Mostaru
Koronarna bolest
![Page 2: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/2.jpg)
Speaker
![Page 3: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/3.jpg)
Country National Coordinator Centres CreatedARMENIA Professor Parounak Zelveian 1
BOSNIA HERZEGOVINA Prof. Emir Fazlibegovic 3
BULGARIA Professor Plamen Gatzov 12
CZECH REPUBLIC Professor Jaromir Hradec 8
EGYPT Dr. Mahmoud Hassanein 27
FRANCE Dr. Damien Logeart 19
GEORGIA Professor Vakhtang Chumburidze 6
ITALY Professor Marco Metra 20
LITHUANIA Professor Ausra Kavoliuniene 2
PORTUGAL Professor Candida Fonseca 11
ROMANIA Dr. Ovidiu Chioncel 13
SERBIA & MONTENEGRO Prof. Petar M. Seferovic 1
SLOVAKIA Professor Eva Goncalvesova 6
Centres already created
![Page 4: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/4.jpg)
Speaker
![Page 5: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/5.jpg)
Speaker
![Page 6: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/6.jpg)
Heart Failure Long Term RegistryAugust, 2012
(n. 10601)
Age (years), mean±SD median [IQR]
65.8±13.25Median=67
Q1=58, Q3=76Age ≥70 years, % 42.4 %Females, % 32.5 %SBP (mmHg), mean±SD 128.71±25.42
EF (%), mean±SD 35.8±14.07n=8105
Diabetes mellitus, % 34.1 %
Baseline characteristicsGlobal data of registry
![Page 7: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/7.jpg)
Heart Failure Long Term RegistryAugust, 2012
(n. 208)
Age (years), mean±SD median [IQR]
69.10±12.48Median=72
Q1=62, Q3=77Age ≥70 years, % 61.1 %Females, % 47.6 %SBP (mmHg), mean±SD 137.48±29.27
EF (%), mean±SD 53.31±14.71n=117
Diabetes mellitus, % 38.0 %
Baseline characteristicsClinical Hospital Mostar - BOSNIA HERZEGOVINA
![Page 8: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/8.jpg)
Heart Failure Long Term RegistryAugust, 2012
Acute HF(n. 5165)
Chronic HF(n. 5436)
Age (years), mean±SD median [IQR]
67.6±12.58Median=69
Q1=60, Q3=77
64±13.63Median=65
Q1=56, Q3=74
Age ≥70 years, % 47.6 % 37.6 %
Females, % 36.8 % 28.5 %
SBP (mmHg), mean±SD 132.5±28.45 125.1±21.56
EF (%), mean±SD 39.3±14.41n=3264
36.8±13.75n=4841
Diabetes mellitus, % 38.3 % 30.0%
Baseline characteristicsGlobal data of registry
(Comparison Acute versus Chronic Heart Failure)
![Page 9: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/9.jpg)
Heart Failure Long Term RegistryAugust, 2012
Acute HF(n. 190)
Chronic HF(n. 18)
Age (years), mean±SD median [IQR]
69.6±12.24Median=73
Q1=65, Q3=77
64.2±14.24Median=61.5
Q1=52, Q3=77
Age ≥70 years, % 63.2% 38.9 %
Females, % 47.9% 44.4 %
SBP (mmHg), mean±SD 138.7±28.1 124.7±38.29
EF (%), mean±SD 53.5±14.72n=115
39.5±4.95n=2
Diabetes mellitus, % 41.1% 5.6 %
Baseline characteristicsClinical Hospital Mostar - BOSNIA HERZEGOVINA
(Comparison Acute versus Chronic Heart Failure)
![Page 10: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/10.jpg)
Speaker
![Page 11: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/11.jpg)
Speaker
![Page 12: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/12.jpg)
Osnovne karakteristike bolesnika
Akutno HF(n. 72)
Kronično HF(n. 118)
Prosječna dob (god.)66,9
M 63,5Ž 70,9
70,8M 68,5Ž 73,3
BMI 27,4 27,8
spol M 39 (54,1%)Ž 33 (45,8%)
M 60 (50,8%)Ž 58 (49,2%)
HTA liječenje D 47 (65,3%)N 25 (34,7%)
D 90 (76,3%)N 28 (23,7%)
mortalitet 8/72 (11,1%) 20/118 (16,9%)
![Page 13: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/13.jpg)
Speaker
ACS and arrhytmias in HFClinical Hospital Mostar - BOSNIA HERZEGOVINA (n=189)
Yes No Yes No Yes NoACS Atrial fibrillation VES / VT, VF
0
20
40
60
80
100
120
9297 94 95
76
113
![Page 14: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/14.jpg)
Speaker
BMI distribution in HFClinical Hospital Mostar - BOSNIA HERZEGOVINA
![Page 15: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/15.jpg)
Speaker
Age and sex distribution in HF-died patients Clinical Hospital Mostar - BOSNIA HERZEGOVINA
<60y 60-69y 70-79y 80-89y0
2
4
6
8
10
12
Male Female
![Page 16: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/16.jpg)
Speaker
Comorbidity in HF-died patients Clinical Hospital Mostar - BOSNIA HERZEGOVINA
Diabete
s
Stroke&
TIA
Periphera
l vascu
lar dise
ase
Hypert
ensio
n
Venous t
hromboembolism
usCOPD
Renal
dysfuncti
on
Depres
sion
0
5
10
15
20
25
YesNo
![Page 17: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/17.jpg)
Akutno vs kronično srčano popuštanje
ponovna hosp. prva hosp.akutno kronično
0
10
20
30
40
50
60
70
80
90
72
35
83
![Page 18: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/18.jpg)
Akutno srčano popuštanje - Etiologija
ishemijska srčana bolest
hipertenzija dilatativna CMP CMP povezana sa tahikardijom
valvularne mane HFPEF ostali0
5
10
15
20
25
30
35
40
45
50
43
11
8 8
2 2 2
![Page 19: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/19.jpg)
Kronično srčano popuštanje - Etiologija
ishemijska srčana bolest
hipertenzija dilatativna CMP CMP povezana sa tahikardijom
valvularne mane HFPEF ostali0
10
20
30
40
50
60
53
2527
6
17
3
![Page 20: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/20.jpg)
Etiologija akutno vs kronično
ishemijska srčana bolest
hipertenzija dilatativna CMP CMP povezana sa tahikardijom
valvularne mane HFPEF ostali0
10
20
30
40
50
60
43
118 8
2 2 2
53
2527
6
17
3
akutno src.pop.kronično src.pop.
![Page 21: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/21.jpg)
Mortalitet
ponovna hosp. prva hosp.akutno kronično
0
10
20
30
40
50
60
70
80
90
72
35
83
8 812
broj pacijenata sa srč.pop.broj umrlih pacijenata
Mortalitet ak.srč.pop. 11,1% (8/72)Mortalitet kron.srč.pop. 16,9% (20/118)
![Page 22: Heart Failure Long-Term Registry](https://reader037.fdocuments.net/reader037/viewer/2022110104/56815f59550346895dce3a85/html5/thumbnails/22.jpg)
Speaker
Zaključak
• Koronarna bolest je najčešći uzrok AHF i CHF kako u ESC registru tako i u registru SKB Mostar.
• Mortalitet od koronarne bolesti je visok u pacijenata sa HF.
• Žene umiru više nego muškarci u dobnoj skupini 70-80 g.
• Veći mortalitet je kod pacijenata s CHF nego sa AHF.
• Komorbidna stanja značajno doprinose mortalitetu u HF.